Nuvaxovid Dosage
Generic name: NVX-COV2705 5ug in 0.5mL
Dosage form: intramuscular injectable suspension
Medically reviewed by Drugs.com. Last updated on May 19, 2025.
For intramuscular use.
Dose and Schedule
Administer NUVAXOVID as a single 0.5 mL dose.
For individuals previously vaccinated with any COVID-19 vaccine, administer the dose of NUVAXOVID at least 2 months after the last dose of COVID-19 vaccine.
Preparation for Administration
- Verify that the label on the pre-filled syringe states 2024 – 2025 Formula.
- NUVAXOVID is a colorless to slightly yellow, clear to mildly opalescent suspension.
- Parenteral drug products should be inspected visually for particulate matter and discoloration prior to administration, whenever solution and container permit. Do not administer the vaccine if either of these conditions exist.
More about Nuvaxovid (sars-cov-2 (covid-19) nvx-cov2705 vaccine, adjuvanted)
Professional resources
Related treatment guides
See also:
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.